|
|
Reliability and regional specificity of glutathione and gamma-aminobutyric acid edited magnetic resonance spectroscopy in the human subcortex |
| 1R03TR004103-01 |
|
NCATS |
2022 |
|
|
Cdc42bpg signaling in arteriosclerosis and vascular fibrosis |
| 1R03TR004144-01 |
|
NCATS |
2022 |
|
|
Elucidating the roles of CACNA2D2 and CACNA2D3 in presynaptic regulation of mammalian synaptic function |
| 1R03TR004161-01 |
|
NCATS |
2022 |
|
|
Engineering Clinical Trials on a Chip for Dystrophin-Deficient Muscular Dystrophy |
| 4UH3TR003271-03 |
|
NCATS |
2022 |
|
|
Optimizing Muscular Dystrophy Clinical Trial Designs using Modeling and Simulation |
| 5R21TR004006-02 |
|
NCATS |
2022 |
|
|
PAR-18-953 (ASCOT-DMD) |
| 5R21TR004007-02 |
|
NCATS |
2022 |
|
|
An in vivo multiplex model to study gene-environment interaction in Parkinsons Disease |
| 1K99ES033723-01A1 |
|
NIEHS |
2022 |
|
|
Interaction of Pyrethroid Exposure and the Microbiome on Parkinsons Disease related Pathologies |
| 1R01ES032440-01A1 |
|
NIEHS |
2022 |
|
|
Microglial Hv1 Proton Channel as a Mediator of Environmentally-Induced Neuroinflammation and Neurodegeneration |
| 1R01ES033892-01 |
|
NIEHS |
2022 |
|
|
Characterizing the link between multiple environmental exposures and Parkinsons disease exacerbation |
| 1R01ES034373-01 |
|
NIEHS |
2022 |
